Skip to main content

Table 2 Summary of differentially expressed serum markers between breast cancer and control subjects

From: The multiplex bead array approach to identifying serum biomarkers associated with breast cancer

Marker

Breast cancer

(Mean ± SD)

Normal

(Mean ± SD)

P valuea

AUC

EGF (pg/ml)

325.14 ± 208.39

76.67 ± 71.42

  

sCD40L (pg/ml)

11226.31 ± 71363.00

32.17 ± 30.35

< 0.001

0.85

HMWK (ug/ml)

19.65 ± 13.49

33.98 ± 15.15

< 0.001

0.76

ApoA1 (ng/ml)

224.36 ± 94.02

322.70 ± 136.80

< 0.001

0.72

sVCAM-1 (ng/ml)

728.05 ± 170.55

832.57 ± 162.23

< 0.001

0.69

PAI-1 (ng/ml)

18.97 ± 6.51

23.38 ± 9.25

< 0.001

0.65

ProApoA1 (ng/ml)

26.74 ± 9823.61

22.14 ± 8.21

< 0.001

0.65

VDBP (ng/ml)

173.65 ± 36.15

191.63 ± 43.57

< 0.001

0.65

VN (ng/ml)

4848.98 ± 2626.57

5546.35 ± 2168.00

0.001

0.64

D-dimer (ng/ml)

1249.58 ± 259.30

539.70 ± 417.99

0.0340

0.59

A1AT (ng/ml)

3594.23 ± 5875.33

3143.05 ± 16616.57

0.808

0.51

CRP (ng/ml)

5154.88 ± 39551.30

2860.52 ± 16501.80

0.818

0.51

AFP (ng/ml)

0.81 ± 0.49

0.76 ± 0.53

0.376

0.54

CEA (ng/ml)

12.36 ± 8.75

10.24 ± 5.11

0.144

0.56

PSA (ng/ml)

0.02 ± 0.05

0.02 ± 0.1

0.750

0.51

CA125 (U/ml)

16.76 ± 71.52

4.91 ± 5.71

0.465

0.53

CA19-9 (U/ml)

60.17 ± 151.07

25.02 ± 20.67

0.016

0.60

B2M (ng/ml)

692.36 ± 166.13

720.68 ± 162.14

0.125

0.56

A2M (ng/ml)

74.00 ± 28.05

85.03 ± 34.28

0.010

0.61

Adiponectin (ng/ml)

12802.04 ± 10393.99

14358.12 ± 6563.28

0.014

0.60

MPO (pg/ml)

146459.9 ± 142930.01

112079.27 ± 100310.31

0.233

0.55

sICAM-1 (ng/ml)

162.31 ± 43.77

173.87 ± 57.84

0.171

0.56

IL-1β (pg/ml)

4.06 ± 11.12

2.74 ± 4.2

0.790

0.51

IL-1Rα (pg/ml)

269.47 ± 361.27

155.37 ± 207.52

0.008

0.61

IL-6 (pg/ml)

36.66 ± 94.93

33.27 ± 75.37

0.720

0.51

IL-8 (pg/ml)

450.89 ± 2970.97

24.24 ± 45.59

0.424

0.53

MCP-1 (pg/ml)

273.38 ± 312.79

280.57 ± 103.93

0.015

0.60

MIP-1α (pg/ml)

76.44 ± 225.17

56.39 ± 88.25

0.224

0.55

ApoA4 (ng/ml)

10382.14 ± 3924.34

10742.81 ± 3755.76

0.544

0.53

TTR (ng/ml)

177.40 ± 58.38

198.27 ± 65.85

0.029

0.59

Hp (ng/ml)

1080.38 ± 662.48

921.74 ± 448.23

0.197

0.55

SAA (ng/ml)

4261.8 ± 9028.56

2872.43 ± 5133.39

0.155

0.56

Hg (ng/ml)

249.95 ± 100.58

82 ± 44.23

< 0.001

0.66

CB (ng/ml)

943.79 ± 110.01

1081.19 ± 847.39

0.003

0.62

ApoH (ng/ml)

125.67 ± 131.69

128.54 ± 31.32

0.520

0.53

  1. aSpecific false discovery rate at a 1% level.
  2. A1AT = alpha-1 antitrypsin; A2M = alpha-2 macroglobulin; AFP = alpha-fetoprotein; Apo = apolipoprotein; AUC = area under the curve; B2M = beta-2 macroglobulin; CA = cancer antigen; CB = cathepsin B; CEA = carcinoembryonic antigen; CRP = C-reactive protein; EGF = epidermal growth factor; Hg = haemoglobin; HMWK = high-molecular-weight kininogen; Hp = haptoglobin; IL = interleukin; MCP = monocyte chemotactic protein; MIP = monocyte inflammatory protein; MPO = myeloperoxidase; PAI = plasminogen activator inhibitor; ProApo = proapolipoprotein; PSA = prostate specific antigen; SAA = serum amyloid A; sCD40L = soluble CD-40 ligand; SD = standard deviation; ICAM = intercellular adhesion molecule; sVCAM = soluble vascular cell adhesion molecule; TTR = transthyretin;VDBP = vitamin-D binding protein; VN = vitronectin.